Proprietary AI analyst is now available
- Public Comps
- Cawachi
Cawachi Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cawachi and similar public comparables like DocMorris, Pague Menos, Cachet Pharmaceuticals, JZJ Chain Drugstore and more.
Cawachi Overview
About Cawachi
Cawachi Ltd is a drug store operator based in Japan. The firm primarily sells pharmaceutical-related products to its customers. It also sells health foods, child care products, cosmetics, grocery, general food and confectionery through its retail outlets. The company operates over 300 stores across Japan.
Founded
1980
HQ

Employees
6.7K
Website
Sectors
Financials (LTM)
EV
$352M
Valuation Multiples
Start free trialCawachi Financials
Cawachi reported last 12-month revenue of $2B.
In the same LTM period, Cawachi generated $20M in net income.
Revenue (LTM)
Cawachi P&L
In the most recent fiscal year, Cawachi reported revenue of $2B and EBITDA of $63M.
Cawachi is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 4%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Cawachi Stock Performance
Cawachi has current market cap of $489M, and enterprise value of $352M.
Market Cap Evolution
Cawachi's stock price is $21.91.
Cawachi share price increased by 6.4% in the last 30 days, and by 26.1% in the last year.
Cawachi has an EPS (earnings per share) of $0.89.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $352M | $489M | -0.6% | 6.4% | 16.3% | 26.1% | $0.89 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCawachi Valuation Multiples
Cawachi trades at 0.2x EV/Revenue multiple, and 5.6x EV/EBITDA.
EV / Revenue (LTM)
Cawachi Financial Valuation Multiples
As of June 17, 2026, Cawachi has market cap of $489M and EV of $352M.
Cawachi has a P/E ratio of 24.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cawachi Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Cawachi Margins & Growth Rates
In the most recent fiscal year, Cawachi reported gross margin of 23%, EBITDA margin of 4%, and net margin of 1%.
Cawachi Margins
Cawachi Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cawachi Operational KPIs
Cawachi's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Cawachi's Rule of 40 is 3% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cawachi's Rule of X is 3% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Cawachi Competitors
Cawachi competitors include DocMorris, Pague Menos, Cachet Pharmaceuticals, JZJ Chain Drugstore, Farmacias Benavides, Great Tree Pharmacy, Zjamp Group, Luyan Pharma, Genky Drug Stores and Dimed SA.
Most Cawachi public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.5x | 0.4x | (12.5x) | (12.9x) | |||
| 0.4x | 0.4x | 5.1x | 5.9x | |||
| 0.2x | - | 7.9x | - | |||
| 0.7x | - | 5.3x | - | |||
| 0.8x | - | 7.3x | - | |||
| 0.8x | 0.8x | 9.2x | 9.6x | |||
| 0.0x | - | 0.5x | - | |||
| 0.4x | - | 13.0x | - | |||
This data is available for Pro users. Sign up to see all Cawachi competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cawachi
| When was Cawachi founded? | Cawachi was founded in 1980. |
| Where is Cawachi headquartered? | Cawachi is headquartered in Japan. |
| How many employees does Cawachi have? | As of today, Cawachi has over 6K employees. |
| Is Cawachi publicly listed? | Yes, Cawachi is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Cawachi? | Cawachi trades under 2664 ticker. |
| When did Cawachi go public? | Cawachi went public in 2002. |
| Who are competitors of Cawachi? | Cawachi main competitors include DocMorris, Pague Menos, Cachet Pharmaceuticals, JZJ Chain Drugstore, Farmacias Benavides, Great Tree Pharmacy, Zjamp Group, Luyan Pharma, Genky Drug Stores, Dimed SA. |
| What is the current market cap of Cawachi? | Cawachi's current market cap is $489M. |
| What is the current revenue of Cawachi? | Cawachi's last 12 months revenue is $2B. |
| What is the current EV/Revenue multiple of Cawachi? | Current revenue multiple of Cawachi is 0.2x. |
| What is the current net income of Cawachi? | Cawachi's last 12 months net income is $20M. |
| How many companies Cawachi has acquired to date? | Cawachi hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Cawachi has invested to date? | Cawachi hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Cawachi
Lists including Cawachi
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.